Abviax's Obefazimod shows strong potential in ulcerative colitis treatment. Upcoming phase 3 trial data in Q3 2025 is a key ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Inside the device, printed semiconductors produce an electrical signal when a targeted DNA or RNA sequence is detected. These electrical reactions are captured digitally and interpreted by a ...